Literature DB >> 8288872

Measurement of eosinophil cationic protein (ECP) and eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN). Time and temperature dependent spontaneous release in vitro demands standardized sample processing.

C M Reimert1, L K Poulsen, C Bindslev-Jensen, A Kharazmi, K Bendtzen.   

Abstract

The measurement of eosinophil derived proteins such as eosinophil cationic protein (ECP) and eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN) in biological fluids may be a useful indicator of eosinophil activity in ongoing inflammatory processes. This study was performed on blood samples and illustrates that serum values of ECP in particular, but also of EPX, are mainly a result of spontaneous release during the processing of blood samples. In the presence of divalent cations (Ca2+ and Mg2+), the amount of released ECP and EPX is dependent upon the incubation temperature and the time before centrifugation and recovery of serum. Moreover, the utensils used for blood sampling may influence the serum levels of ECP and EPX. Thus, standardized sample processing is of paramount importance if the results are to have optimal diagnostic or clinical value.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8288872     DOI: 10.1016/0022-1759(93)90359-f

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel.

Authors:  Claus M Reimert; Colin M Fitzsimmons; Sarah Joseph; Joseph K Mwatha; Frances M Jones; Gachuhi Kimani; Karl F Hoffmann; Mark Booth; Narcis B Kabatereine; David W Dunne; Birgitte J Vennervald
Journal:  Clin Vaccine Immunol       Date:  2006-05

2.  CCL11 elicits secretion of RNases from mouse eosinophils and their cell-free granules.

Authors:  Revital Shamri; Rossana C N Melo; Kristen M Young; Maytal Bivas-Benita; Jason J Xenakis; Lisa A Spencer; Peter F Weller
Journal:  FASEB J       Date:  2012-01-31       Impact factor: 5.191

3.  Perturbations in eosinophil homeostasis following treatment of lymphatic filariasis.

Authors:  R Gopinath; L E Hanna; V Kumaraswami; V Perumal; V Kavitha; V Vijayasekaran; T B Nutman
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

4.  Increased eosinophil activity in acute Plasmodium falciparum infection--association with cerebral malaria.

Authors:  J A Kurtzhals; C M Reimert; E Tette; S K Dunyo; K A Koram; B D Akanmori; F K Nkrumah; L Hviid
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.